Shopping Cart
- Remove All
- Your shopping cart is currently empty
Cobolimab (TSR-022) is a potent monoclonal antibody to TIM-3. Cobolimab induces internalization of TIM-3 with an IC50 value of 0.4464 nM. Cobolimab has antitumor activity and can be used to study advanced/metastatic melanoma and advanced hepatocellular carcinoma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $249 | In Stock | |
5 mg | $647 | In Stock | |
10 mg | $970 | In Stock |
Description | Cobolimab (TSR-022) is a potent monoclonal antibody to TIM-3. Cobolimab induces internalization of TIM-3 with an IC50 value of 0.4464 nM. Cobolimab has antitumor activity and can be used to study advanced/metastatic melanoma and advanced hepatocellular carcinoma. |
Targets&IC50 | TIM3:0.4464 nM |
In vitro | Cobolimab (0.0001-10 nM; 3 days) promotes dose-dependent internalization of TIM-3 in pre-activated T cells with an IC50 of 0.4464 nM[4], and at 20 µg/mL for 24 hours, significantly increases the content of CD8+ T cells by inhibiting TIM-3[3]. |
Alias | TSR-022, GSK4069889 |
Molecular Weight | 142.84 kDa |
Cas No. | 2022215-65-0 |
Storage | store at low temperature | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.